Genetic polymorphism of renin-angiotensin-aldosterone system in type 2 diabetes and in combination with arterial hypertension among Dagestan inhabitants

Genetic polymorphism of renin-angiotensin-aldosterone system in type 2 diabetes and in combination with arterial hypertension among Dagestan inhabitants

BACKGROUND: Type 2 diabetes and arterial hypertension are frequent comorbidities under which activation the renin-angiotensin-aldosterone system is important pathogenetic link. The functional state of the RAAS is genetically determined. Genetic polymorphisms of the RAAS system associated with the de...

Full description

Bibliographic Details
Main Authors:	Marat Z. Saidov, Suleiman N. Mammaev, Halina M. Magadova, Rita Maratovna Balamirzoeva, Zulfia Sh. Magomedova, Zarema S. Magomedova, Aishat U. Gamzaeva
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2019-12-01
Series:	Сахарный диабет
Subjects:	diabetes mellitus essential arterial hypertension genes polymorphism renin-angiotensin-aldosterone system
Online Access:	https://www.dia-endojournals.ru/jour/article/view/10207

Similar Items

Association of angiotensinogen and angiotensin II receptor type I polymorphisms with biomarkers of carbohydrate and lipid metabolism in Dagestan residents with type 2 diabetes and hypertension
by: M. Z. Saidov, et al.
Published: (2021-11-01)

Aldosterone-to-renin ratio (ARR) as a screening tool for primary aldosteronism (PA)
by: Chia-Hung Lin, et al.
Published: (2024-03-01)

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
by: M L Maksimov
Published: (2010-06-01)

Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension
by: Fabio Bioletto, et al.
Published: (2023-05-01)

The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
by: Kazuyuki Hirooka, et al.
Published: (2022-03-01)

Survey of renin and aldosterone testing practices by Ontario laboratories – Providing insight into best practices
by: Angela C. Rutledge, et al.
Published: (2021-05-01)

The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
by: Ming-Hui Zheng, et al.
Published: (2020-08-01)

Regulation of the renin-angiotensin-aldosterone system by cyclic nucleotides and phosphodiesterases
by: Stepan Gambaryan, et al.
Published: (2023-08-01)

Activation of the renin-angiotensin-aldosterone system in mares around ovulation
by: Katy Satué, et al.
Published: (2017-06-01)

How to potentialize the effect of renin-angiotensin-aldosterone system inhibitors?
by: D.D. Ivanov
Published: (2021-09-01)

Effect of calcifediol supplementation on renin‐angiotensin‐aldosterone system mediators in dogs with chronic kidney disease
by: Matthew Miller, et al.
Published: (2022-09-01)

Heightened Cardiovascular Risk in Hypertension Associated With Renin‐Independent Aldosteronism Versus Renin‐Dependent Aldosteronism: A Collaborative Study
by: Jinbo Hu, et al.
Published: (2021-12-01)

Diet‐induced prediabetes: Effects on the activity of the renin–angiotensin–aldosterone system in selected organs
by: Bongeka Cassandra Mkhize, et al.
Published: (2022-05-01)

Quantitative Value of Aldosterone‐Renin Ratio for Detection of Aldosterone‐Producing Adenoma: The Aldosterone‐Renin Ratio for Primary Aldosteronism (AQUARR) Study
by: Giuseppe Maiolino, et al.
Published: (2017-05-01)

The state of renin-aldosterone system in patients with resistant arterial hypertension
by: О. H. Оbertynska
Published: (2019-06-01)

Dynamic changes of renin-angiotensin-aldosterone system parameters after surgery of primary hyperparathyroidism
by: E. A. Dobreva, et al.
Published: (2020-11-01)

The influence of renin angiotensin aldosterone system blockers on asymmetric dimethylarginine levels in patients with chronic glomerulonephritis
by: Heleniak Zbigniew, et al.
Published: (2016-12-01)

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM GENES POLYMORPHISM AND RELATION WITH VASOPRESSORS IN ESSENTIAL HYPERTENSION AMONG DAGESTAN INHABITANTS
by: M. Z. Saidov, et al.
Published: (2017-05-01)

Renin-angiotensin-aldosteron system: evolution of views from renin discovery to nowadays. Perspectives of therapeutic block
by: Marina Vladimirovna Shestakova, et al.
Published: (2011-04-01)

Gender differences renin-angiotensin-aldosterone system and its relation to humoral factors in patients with arterial hypertension
by: G M Dadashova
Published: (2015-09-01)

The effect of medication on the aldosterone‐to‐renin ratio. A critical review of the literature
by: Rawan M. Alnazer, et al.
Published: (2021-02-01)

Renal denervation inhibits the renin–angiotensin–aldosterone system in spontaneously hypertensive rats
by: Fei Qin, et al.
Published: (2022-01-01)

The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19
by: Annamaria Mascolo, et al.
Published: (2021-04-01)

Renin-angiotensin-aldosterone system blockers as the main pathogenetic approach of drug nephroprotection
by: N.D. Filipets, et al.
Published: (2019-02-01)

Prevalence of aldosterone breakthrough in dogs receiving renin‐angiotensin system inhibitors for proteinuric chronic kidney disease
by: Marisa K. Ames, et al.
Published: (2022-11-01)

The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism
by: Piotr Jędrusik, et al.
Published: (2021-05-01)

Comparison of the Chemiluminescence Immunoassay LIAISON® with the Radioimmunoassay for Aldosterone and Renin Measurement
by: Jana Uhrová, et al.
Published: (2021-06-01)

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING
by: V. S. Pykhtina, et al.
Published: (2015-09-01)

The activity of the renin-angiotensin-aldosterone system before and after parathyroidectomy in patients with primary hyperparathyroidism
by: Liubov G. Yanevskaya, et al.
Published: (2021-12-01)

Patients with pheochromocytoma exhibit low aldosterone renin ratio-preliminary reports
by: Tomoko Yamada, et al.
Published: (2020-09-01)

Effect of sodium–glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in diabetic patients with hypertension: a retrospective observational study
by: Toshitaka Sawamura, et al.
Published: (2020-11-01)

Implications of Plasma Renin Activity and Plasma Aldosterone Concentration in Critically Ill Patients with Septic Shock
by: Kyung Soo Chung, et al.
Published: (2017-05-01)

Relation of the renin–angiotensin–aldosterone system with potential cardiac injury and remodelling: the SABPA study
by: Lebo F. Gafane-Matemane, et al.
Published: (2020-01-01)

Left ventricular hypertrophy and renin-angiotensin-aldosterone system: AT1-receptor blockers are in the focus
by: A V Barsukov, et al.
Published: (2013-03-01)

The interacting physiology of COVID‐19 and the renin‐angiotensin‐aldosterone system: Key agents for treatment
by: Eugenie R. Lumbers, et al.
Published: (2022-02-01)

Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Cancer: A Population-Based Cohort Study Using a Common Data Model
by: Seung-Hwa Lee, et al.
Published: (2022-01-01)

Arterial hypertension in hypothyrosis: severity and state of renin-aldosteron system
by: G. B. Selivanova, et al.
Published: (2004-06-01)

Bidirectional relationship between covid-19 and diabetes: Role of renin–angiotensin–aldosterone system and drugs modulating it
by: Razia Khanam
Published: (2021-01-01)

Renin-angiotensin-aldosterone system in patients with COVID-19
by: Giacomo Fedi, et al.
Published: (2020-12-01)

The functional state of the kallikrein-kinin and renin-angiotensin-aldosterone systems in patients with localized kidney cancer
by: N. D. Ushakova, et al.
Published: (2021-12-01)